GO:0001681 sialate O-acetylesterase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001681 sialate O-acetylesterase activity catalyzes the hydrolysis of O-acetyl groups from N-acetyl-O-acetylneuraminate (free or glycosidically bound), releasing acetate and N-acetylneuraminate.
• This enzymatic activity is essential for the complete degradation of sialic acids and for modulating their biological recognition, as O-acetylation can mask or alter sialic acid functions.
• Sialate O-acetylesterases are found in diverse organisms, including bacteria, viruses, and humans, and are involved in host-pathogen interactions, mucin degradation, and immune evasion [1, 5, 6].
• Dysregulation of sialate O-acetylesterase activity has been linked to diseases such as childhood acute lymphoblastic leukemia and may influence the stability of biopharmaceuticals [3, 7].
• Key genes encoding sialate O-acetylesterases include NanS from Tannerella forsythia, NanS-p from Stx2a bacteriophages, and the influenza C virus esterase, among others [1, 2, 6].
• Studying this activity requires specialized assays, and CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise functional dissection in relevant cell types.
Description
Sialate O-acetylesterase activity (GO:0001681) is a molecular function that removes O-acetyl groups from sialic acids, a modification that profoundly affects their chemical properties and biological roles. Sialic acids are nine-carbon sugars often found at the termini of glycoproteins and glycolipids, where they mediate cell-cell interactions, immune recognition, and pathogen binding. The O-acetylation status of sialic acids is dynamically regulated by opposing activities: sialate O-acetyltransferases add acetyl groups, while sialate O-acetylesterases remove them [4, 7]. This balance is critical for normal physiology and is subverted in various disease states. Researchers study sialate O-acetylesterase activity to understand how sialic acid modifications influence processes such as mucin degradation, viral entry, and cancer progression [1, 5, 7]. The enzyme is also of biotechnological interest because it can degrade polysorbate 20 in monoclonal antibody formulations, affecting drug stability. Thus, GO:0001681 represents a key enzymatic activity at the interface of glycobiology, microbiology, and medicine.
sialate O-acetylesterase activity At A Glance
| GO ID | GO:0001681 |
|---|---|
| GO term | sialate O-acetylesterase activity |
| Ontology | molecular_function |
| Synonym | N-acetylneuraminate acetyltransferase activity |
| Definition | Catalysis of the reaction: N-acetyl-O-acetylneuraminate (free or glycosidically bound) + H2O = N-acetylneuraminate + acetate. |
| Major function | Hydrolysis of O-acetyl groups from sialic acids, modulating their structure and function. |
| Substrate | N-acetyl-O-acetylneuraminate (free or glycosidically bound) |
| Products | N-acetylneuraminate and acetate |
| Cellular location | Varies by organism; secreted or intracellular (e.g., bacterial periplasm, viral envelope, mammalian lysosomes). |
| Associated genes | NanS (Tannerella forsythia), NanS-p (bacteriophages), influenza C virus esterase, and mammalian homologs. |
What Is GO:0001681?
Sialate O-acetylesterase activity (GO:0001681) is defined as the catalysis of the reaction: N-acetyl-O-acetylneuraminate (free or glycosidically bound) + H2O = N-acetylneuraminate + acetate. In other words, it is an enzyme that cleaves the O-acetyl group from O-acetylated sialic acid molecules, releasing free acetate and leaving N-acetylneuraminate (a common sialic acid). This activity can act on both free and glycosidically bound substrates, meaning it can modify sialic acids that are part of larger glycoconjugates.
Why Is sialate O-acetylesterase activity Important in Cell Biology?
Sialate O-acetylesterase activity is important because it regulates the O-acetylation state of sialic acids, which in turn affects cell surface recognition, immune evasion by pathogens, and the stability of therapeutic proteins [3, 5, 7]. O-acetylation of sialic acids can alter their binding to lectins and antibodies, and removal by esterases can expose underlying sugars for further degradation or recognition [1, 5]. In bacteria, this activity contributes to the degradation of host mucins and sialic acid utilization, influencing colonization and pathogenesis [1, 5]. In viruses, it is essential for the influenza C virus life cycle, as the virus uses its esterase to destroy receptors and facilitate release. In humans, altered sialate O-acetylesterase activity has been observed in childhood acute lymphoblastic leukemia, suggesting a role in cancer biology. Additionally, the enzyme can inadvertently degrade polysorbate 20 in biopharmaceutical formulations, posing challenges for drug manufacturing. Therefore, understanding this activity is crucial for microbiology, virology, cancer research, and biotechnology.
• Regulates sialic acid O-acetylation, affecting cell-cell and cell-pathogen interactions.
• Enables complete degradation of sialic acids in bacteria, contributing to mucin breakdown and nutrient acquisition [1, 5].
• Plays a role in viral pathogenesis, such as influenza C virus receptor destruction and release.
• Modulates immune recognition by altering sialic acid epitopes on cell surfaces.
• Linked to childhood acute lymphoblastic leukemia, where altered activity may affect disease progression.
• Impacts the stability of monoclonal antibody formulations by degrading polysorbate 20.
• Serves as a potential target for antibacterial and antiviral strategies [1, 6].
• Provides a tool for glycoengineering and studying sialic acid biology.
• Involved in host-microbe interactions in the human colon.
• Its assay is used to screen for enzyme inhibitors and to characterize enzyme specificity.
Molecular Mechanism of sialate O-acetylesterase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs onto the O-acetylated sialic acid molecule.
Sialate O-acetylesterases specifically recognize N-acetyl-O-acetylneuraminate, either free or as part of a larger glycan chain. The enzyme's active site contains residues that form hydrogen bonds and hydrophobic interactions with the sialic acid core, positioning the O-acetyl group for catalysis. For example, the NanS enzyme from Tannerella forsythia has been shown to preferentially act on 9-O-acetylated sialic acids, and its activity enhances the release of sialic acid by its cognate sialidase, NanH. The specificity for the O-acetyl group versus other acyl groups is determined by the shape and chemical environment of the binding pocket.
Catalytic Hydrolysis
In simple terms: A water molecule attacks the acetyl group, breaking it off.
The catalytic mechanism involves a water molecule that is activated by a general base (often a histidine or aspartate residue) to attack the carbonyl carbon of the O-acetyl group. This leads to the formation of a tetrahedral intermediate, which collapses to release acetate and the de-O-acetylated sialic acid (N-acetylneuraminate). The reaction is a typical ester hydrolysis, and the enzyme may employ a serine hydrolase-like mechanism or a metal-dependent mechanism depending on the family. For instance, the influenza C virus esterase uses a serine hydrolase catalytic triad. The reaction is reversible in principle, but under physiological conditions, hydrolysis is favored.
Cofactors and Metal Dependence
In simple terms: Some versions of the enzyme need a metal helper, others do not.
Sialate O-acetylesterases vary in their cofactor requirements. Some bacterial enzymes, such as NanS from Tannerella forsythia, do not require metal ions for activity. In contrast, certain esterases may be activated by divalent cations like calcium or magnesium, although this is not universal. The influenza C virus esterase is a serine hydrolase and does not require metals. Researchers should consider these differences when designing assays, as buffer conditions can affect activity.
Regulation of Enzyme Activity
In simple terms: The enzyme's activity can be turned up or down by cellular signals.
The activity of sialate O-acetylesterases can be regulated at multiple levels. In bacteria, expression of the nanS gene is often controlled by sialic acid availability and global regulators. In humans, the balance between O-acetylation and de-O-acetylation is maintained by the opposing actions of sialate O-acetyltransferases and esterases, and this balance can be disrupted in disease. For example, in childhood acute lymphoblastic leukemia, altered expression of these enzymes leads to changes in sialic acid O-acetylation patterns. Additionally, the enzyme's activity can be influenced by post-translational modifications, although specific examples are less documented.
Substrate Specificity and Isoforms
In simple terms: Different enzymes prefer different positions of the acetyl group.
Sialate O-acetylesterases can be specific for the 9-O-acetyl or 4-O-acetyl group on sialic acid. For instance, the influenza C virus esterase specifically removes 9-O-acetyl groups. The NanS from Tannerella forsythia also acts on 9-O-acetylated sialic acids. In Streptococcus suis serotype 2, the NeuA protein exhibits O-acetylesterase activity specific for CMP-activated O-acetyl sialic acid, indicating that substrate specificity can extend to nucleotide-activated forms. This specificity is determined by the active site architecture and is crucial for biological function.
Key Genes Involved in GO:0001681 sialate O-acetylesterase activity
The following genes and proteins are known to possess or regulate sialate O-acetylesterase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NanS (Tannerella forsythia) | Sialate O-acetylesterase that enhances sialic acid release by NanH sialidase | Oral pathogen virulence; mucin degradation |
| NanS-p (bacteriophages) | Sialate O-acetylesterase encoded in Stx2a bacteriophages | Phage biology; Shiga toxin regulation |
| Influenza C virus esterase | 9-O-acetylesterase essential for viral release | Viral pathogenesis; receptor destruction |
| NeuA (Streptococcus suis) | O-acetylesterase specific for CMP-activated O-acetyl sialic acid | Bacterial capsule synthesis; immune evasion |
| Human sialate O-acetylesterase (e.g., SIAE) | Regulates O-acetylation of sialic acids in humans | Autoimmunity; leukemia |
| Sialate O-acetyltransferase (e.g., CASD1) | Opposing enzyme that adds O-acetyl groups | Balance of sialic acid modification |
| NanH (Tannerella forsythia) | Sialidase that works with NanS | Synergistic sialic acid degradation |
| Stx2a phage genes | Flanking region of Shiga toxin operon | Phage diversity; toxin production |
| Polysorbate 20-degrading esterase | Hydrolyzes polysorbate 20 in mAb formulations | Biopharmaceutical stability |
| Fecal bacterial esterases | Contribute to mucin degradation in colon | Gut microbiome; colon health |
| Sialate O-acetylesterase (assay standard) | Used to develop enzyme assays | Glycobiology research |
| CMP-sialic acid O-acetylesterase | Acts on nucleotide sugar | Bacterial sialylation |
| 9-O-acetylesterase (influenza C) | Viral enzyme | Antiviral targets |
| 4-O-acetylesterase (various) | Removes 4-O-acetyl groups | Substrate specificity studies |
| SIAE variants | Human genetic variants | Autoimmune disease associations |
| NanS homologs in gut bacteria | Sialic acid metabolism | Microbiome-host interactions |
| Sialate O-acetylesterase in leukemia | Altered activity in ALL | Cancer biomarker |
| Polysorbate-degrading enzymes | Contaminants in bioprocessing | Quality control |
How Is sialate O-acetylesterase activity Regulated?
Sialate O-acetylesterase activity is regulated at multiple levels. In bacteria, expression of genes such as nanS is often induced by sialic acids and subject to catabolite repression. In humans, the overall O-acetylation state of sialic acids is determined by the balance between sialate O-acetyltransferases and sialate O-acetylesterases, and this balance can be altered in disease states such as childhood acute lymphoblastic leukemia. Additionally, the activity of the influenza C virus esterase is regulated by the viral life cycle, with the enzyme playing a critical role in receptor destruction and viral release. Post-translational modifications and cellular localization may also influence activity, although specific mechanisms are less well defined.
sialate O-acetylesterase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SIAE (human) | Childhood acute lymphoblastic leukemia; autoimmunity | Knockout or overexpression in leukemia cell lines (e.g., Jurkat) |
| NanS (Tannerella forsythia) | Oral pathogen virulence; mucin degradation | Bacterial knockout and mouse oral infection model |
| Influenza C virus esterase | Influenza C virus infection | Viral reverse genetics; cell culture models |
| NeuA (Streptococcus suis) | Bacterial capsule synthesis; immune evasion | Streptococcus suis knockout and macrophage infection assays |
| Polysorbate-degrading esterase | Biopharmaceutical instability | CHO cell expression and formulation studies |
Childhood Acute Lymphoblastic Leukemia
Alterations in the regulation of O-acetylation of sialic acids, involving both sialate O-acetyltransferase and sialate O-acetylesterase activities, have been observed in childhood acute lymphoblastic leukemia. The study by Mandal et al. (2012) suggests that the balance of these opposing activities is disrupted in leukemia, potentially affecting cell surface sialylation and contributing to disease pathology. This highlights sialate O-acetylesterase as a potential biomarker or therapeutic target in leukemia.
Influenza C Virus Infection
The influenza C virus relies on its sialate 9-O-acetylesterase to destroy receptors and facilitate viral release from infected cells. The enzyme is essential for the viral life cycle, and its activity has been characterized in detail. Inhibitors of this esterase could serve as antiviral agents, making it a target for drug development.
Bacterial Pathogenesis and Mucin Degradation
Sialate O-acetylesterases from bacteria such as Tannerella forsythia and fecal bacteria contribute to the degradation of mucins in the human colon. This activity, together with sialidases, allows bacteria to access sialic acids as a nutrient source and may promote colonization and pathogenesis [1, 5]. In oral pathogen Tannerella forsythia, NanS enhances sialic acid release by NanH, facilitating bacterial survival.
Biopharmaceutical Stability
Sialate O-acetylesterase activity can degrade polysorbate 20, a common surfactant in monoclonal antibody formulations, leading to particle formation and reduced drug stability. Zhang et al. (2021) identified this activity as a cause of polysorbate 20 degradation in biopharmaceuticals, highlighting the need for control strategies.
From sialate O-acetylesterase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of NanS in sialic acid utilization? | NanS knockout in Tannerella forsythia, growth assays with sialylated substrates |
| How does sialate O-acetylesterase affect leukemia cell surface sialylation? | CRISPR knockout of SIAE in human leukemia cell lines, flow cytometry with lectins |
| Does influenza C virus esterase activity correlate with viral release? | Point mutations in catalytic residues, viral plaque assays |
| Can sialate O-acetylesterase degrade polysorbate 20 in mAb formulations? | Overexpression of esterase in CHO cells, polysorbate 20 stability assays |
| What is the substrate specificity of NeuA from Streptococcus suis? | Knockout of neuA, complementation with point mutants, enzymatic assays with CMP-sialic acid |
| How does O-acetylation balance affect immune recognition? | Knock-in of tagged SIAE in primary immune cells, co-culture with NK cells |
How to Study the sialate O-acetylesterase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay with 4-MU-acetate | Esterase activity | Kinetic characterization of purified enzymes |
| HPLC-based acetate release | Substrate hydrolysis | Quantification of enzyme activity in cell lysates |
| CRISPR knockout | Loss-of-function phenotype | Studying gene function in bacteria or human cells [1, 7] |
| Overexpression | Gain-of-function effects | Enzyme production and substrate specificity |
| Lectin flow cytometry | Cell surface sialic acid O-acetylation | Analyzing changes in sialylation upon esterase modulation |
| Mass spectrometry glycomics | Detailed glycan structures | Profiling O-acetylation patterns |
| Viral plaque assay | Viral replication and release | Assessing influenza C esterase mutants |
| Polysorbate 20 degradation assay | Surfactant stability | Biopharmaceutical formulation testing |
Enzymatic Assays for Sialate O-Acetylesterase Activity
Direct measurement of sialate O-acetylesterase activity typically uses synthetic substrates such as 4-methylumbelliferyl acetate or natural substrates like 9-O-acetylated sialic acid. The release of acetate can be quantified using coupled enzymatic assays or by high-performance liquid chromatography (HPLC). Srinivasan et al. (2009) described detailed assays for both sialate O-acetyltransferases and esterases, providing a foundation for kinetic studies. These assays are essential for characterizing enzyme specificity, kinetics, and inhibitor screening.
Genetic Knockout and Knockdown Models
CRISPR-Cas9 knockout of genes encoding sialate O-acetylesterases (e.g., NanS, SIAE) allows researchers to assess loss-of-function phenotypes. For example, knocking out nanS in Tannerella forsythia can reveal its role in sialic acid metabolism and host interaction. In human cells, knockdown of SIAE using siRNA or CRISPR can elucidate its function in leukemia cells. These models are crucial for linking enzyme activity to cellular processes.
Overexpression and Tagged Knock-in for Localization
Overexpression of sialate O-acetylesterases in bacterial or mammalian cells can be used to study enzyme function, substrate specificity, and effects on sialylation. Tagged knock-in (e.g., GFP or FLAG) enables visualization of subcellular localization and protein interactions. For instance, tagging the influenza C virus esterase has helped track its trafficking during infection. These approaches provide insights into enzyme regulation and dynamics.
Glycomic and Proteomic Profiling
Mass spectrometry-based glycomics can profile changes in sialic acid O-acetylation upon modulation of esterase activity. Proteomics can identify interacting proteins and post-translational modifications. Such studies have revealed that sialate O-acetylesterase activity affects the overall sialylation pattern in cells, which can be monitored using lectin microarrays or mass spectrometry. These methods are powerful for systems-level understanding.
How CRISPR Can Be Used to Study GO:0001681 sialate O-acetylesterase activity
Knockout
CRISPR-Cas9 knockout of genes encoding sialate O-acetylesterases (e.g., NanS, SIAE, NeuA) creates null alleles to study loss of function. For example, knocking out nanS in Tannerella forsythia can reveal its role in sialic acid utilization and virulence. In human cells, SIAE knockout can help determine its contribution to leukemia cell proliferation and sialylation. Knockout models are essential for validating gene function and identifying downstream effects.
Point Mutation
Introducing point mutations in catalytic residues (e.g., serine, histidine, aspartate) of sialate O-acetylesterases can abolish enzymatic activity while preserving protein structure. This is useful for dissecting the enzymatic versus non-enzymatic functions. For instance, mutating the catalytic serine of influenza C virus esterase confirmed its essential role in viral release. Point mutations can also model human genetic variants associated with disease.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of sialate O-acetylesterases allows real-time tracking of localization and interaction partners. This approach can be used to study the enzyme's trafficking in bacteria or mammalian cells. For example, tagging NanS in Tannerella forsythia could reveal its secretion and association with the cell surface. Knock-in of disease-associated mutations can also model their effects on enzyme activity.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression vectors can drive high-level expression of sialate O-acetylesterases to study gain-of-function phenotypes. Overexpression in CHO cells has been used to study polysorbate 20 degradation by esterases. In bacteria, overexpression can enhance sialic acid degradation and reveal substrate range. This approach is valuable for producing recombinant enzyme for structural and biochemical studies.
How EDITGENE Supports sialate O-acetylesterase activity Research
Researchers studying sialate O-acetylesterase activity-related genes often need to determine whether a candidate gene is causally involved in sialic acid metabolism, host-pathogen interactions, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for sialate O-acetylesterase activity research.
Frequently Asked Questions About sialate O-acetylesterase activity
What is sialate O-acetylesterase activity?
Sialate O-acetylesterase activity (GO:0001681) is an enzymatic function that removes O-acetyl groups from N-acetyl-O-acetylneuraminate (sialic acid), releasing acetate and N-acetylneuraminate.
What genes are involved in sialate O-acetylesterase activity?
Genes include NanS from Tannerella forsythia, NanS-p from bacteriophages, influenza C virus esterase, NeuA from Streptococcus suis, and human SIAE [1, 2, 6, 8].
What diseases are linked to sialate O-acetylesterase activity?
It has been linked to childhood acute lymphoblastic leukemia, influenza C virus infection, bacterial pathogenesis, and biopharmaceutical instability [3, 6, 7].
How is sialate O-acetylesterase activity measured?
It is measured using enzymatic assays with synthetic or natural substrates, often coupled with HPLC or mass spectrometry to detect acetate release or substrate consumption.
What is the role of sialate O-acetylesterase in bacteria?
In bacteria, it helps degrade mucins and utilize sialic acids as nutrients, and can enhance sialidase activity, contributing to colonization and virulence [1, 5].
How does sialate O-acetylesterase affect influenza C virus?
The influenza C virus esterase destroys receptors to facilitate viral release, and is essential for the viral life cycle.
Can sialate O-acetylesterase degrade polysorbate 20?
Yes, sialate O-acetylesterase activity has been shown to degrade polysorbate 20 in monoclonal antibody formulations, affecting drug stability.
What is the difference between sialate O-acetyltransferase and sialate O-acetylesterase?
Sialate O-acetyltransferase adds O-acetyl groups to sialic acids, while sialate O-acetylesterase removes them, together maintaining the O-acetylation balance [4, 7].
How can CRISPR be used to study sialate O-acetylesterase activity?
CRISPR can create knockout, point mutation, knock-in, or overexpression models to dissect gene function and enzyme activity in relevant cell types [1, 7].
What are the substrates of sialate O-acetylesterase?
The substrates are N-acetyl-O-acetylneuraminate, either free or glycosidically bound, such as 9-O-acetylated sialic acids on glycoproteins.
Conclusion
Sialate O-acetylesterase activity (GO:0001681) is a critical enzymatic function that regulates the O-acetylation state of sialic acids, impacting diverse biological processes from bacterial pathogenesis to viral infection and human disease. Understanding its mechanism, regulation, and role in disease requires robust experimental models. CRISPR-based approaches offer precise tools to manipulate genes encoding this activity, enabling researchers to uncover new insights. EDITGENE's services support these efforts with custom knockout, point mutation, knock-in, overexpression, and screening solutions.
References
- 1. Phansopa C et al.. 2015. Characterization of a sialate-O-acetylesterase (NanS) from the oral pathogen Tannerella forsythia that enhances sialic acid release by NanH, its cognate sialidase.. Biochem J 472(2):157-67 PMID: 26378150
- 2. Pascal SB et al.. 2023. Characterization of the flanking region of the Shiga toxin operon in Stx2a bacteriophages reveals a diversity of the NanS-p sialate O-acetylesterase gene.. AIMS Microbiol 9(3):570-590 PMID: 37649799
- 3. Zhang S et al.. 2021. Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations.. J Pharm Sci 110(12):3866-3873 PMID: 34487744
- 4. Srinivasan GV et al.. 2009. Assays of sialate-O-acetyltransferases and sialate-O-acetylesterases.. Glycoconj J 26(8):935-44 PMID: 18566887
- 5. Corfield AP et al.. 1992. Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria.. Infect Immun 60(10):3971-8 PMID: 1398908
- 6. Schauer R et al.. 1988. Isolation and characterization of sialate 9(4)-O-acetylesterase from influenza C virus.. Biol Chem Hoppe Seyler 369(10):1121-30 PMID: 3242542
- 7. Mandal C et al.. 2012. Regulation of O-acetylation of sialic acids by sialate-O-acetyltransferase and sialate-O-acetylesterase activities in childhood acute lymphoblastic leukemia.. Glycobiology 22(1):70-83 PMID: 21803834
- 8. Song L et al.. 2011. NeuA O-acetylesterase activity is specific for CMP-activated O-acetyl sialic acid in Streptococcus suis serotype 2.. Biochem Biophys Res Commun 410(2):212-7 PMID: 21624352
